New Zealand shares gained in light trading as Fletcher Building's discounted rights issue and upcoming MSCI New Zealand index review weighed on investors' minds. Trade Me and Metlifecare increased while Comvita dropped.
The S&P/NZX 50 index rose 24.97 points, or 0.3 per cent, to 8,369.49. Within the index, 21 stocks gained, 22 fell, and seven were unchanged. Turnover was $85 million, extending yesterday's lacklustre activity.
Fletcher Building remained in a trading halt at $6.27 as investors continue to digest yesterday's underwritten $750m rights issue at a 23 per cent discount. After the close of trading, the company said institutional investors took up 98 percent of their entitlements, raising gross proceeds of $500m. The institutional bookbuild opens tonight and runs until the close of business tomorrow before trading resumes on Friday.
The capital raise is part of a $1.25 billion refinancing plan shoring up the construction company's balance sheet having drawn $280m from its banking facility in the first three months of this year alone. Fletcher also announced plans to sell Formica and its steel roofing tiles business, which Morningstar Research estimates are worth about $700m.
"There are a lot of facets in that stock - it is difficult to read with clarity where it will go," said James Lindsay, a senior portfolio manager at Nikko Asset Management.